Profil
Greg Troiano formerly worked at Translate Bio, Inc., as Chief Manufacturing Officer in 2021.
Mr. Troiano received his undergraduate degree and graduate degree from The Johns Hopkins University.
Anciens postes connus de Greg Troiano
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 14/09/2021 |
Formation de Greg Troiano
| The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Relations
20
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |